Blood test may replace needle biopsy for thyroid cancer
NCT ID NCT04742608
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a blood test can diagnose thyroid cancer as accurately as a traditional biopsy. Researchers will analyze tiny particles called extracellular vesicles from blood and tissue samples of 250 adults with thyroid nodules or cancer. The goal is to find a less invasive way to detect cancer and guide treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to diagnose thyroid cancer, avoiding the need for invasive biopsies.
- What could go wrong
- This is an early-stage observational study, so it may not lead to a reliable diagnostic test. The results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID GLAND CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET tracer could spot cancers that standard scans overlook
- New DNA test could spare thousands from unnecessary thyroid surgery
- New MRI technique may predict cancer treatment success early
- New PET tracer could spot hidden cancers
- Heat and radiation team up to fight spine cancer
- 2000 volunteers help create a gold standard for cancer blood tests